Arena Pharmaceuticals Inc (NASDAQ:ARNA)

Delayed Data
As of Mar 16
 -1.50 / -4.54%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 7 analysts offering 12-month price forecasts for Arena Pharmaceuticals Inc have a median target of 44.00, with a high estimate of 56.00 and a low estimate of 34.00. The median estimate represents a +39.64% increase from the last price of 31.51.

Analyst Recommendations

The current consensus among 8 polled investment analysts is to Buy stock in Arena Pharmaceuticals Inc. This rating has held steady since February, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
May 09

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -79.55%
Growthannually 7.14%


Growthquarterly -64.20%
Growthannually 9.36%
Key to the earnings and sales forecast charts.